CI

CeriBell, Inc.

CBLL·NASDAQ

$18.63

+6.5%
HealthcareMedical - Devices

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

At a Glance

Live Snapshot
Market Cap$706.87M
EPS-1.4600
P/E Ratio-12.76
Earnings Date08/04/2026

cbll

Depreciation and Amortization

Last Annual Value

-670.00K

3-Year CAGR

-33%

5-Year CAGR

-19%

10-Year CAGR

-9%

CI

CeriBell, Inc. Competitors Analysis of Depreciation and Amortization

CBLL · NASDAQ
CompanyDepreciation and Amortization
CAGR 3Y
CAGR 5Y
CAGR 10Y
CBLL logo
CeriBell, Inc.
NASDAQ:CBLL
-670.00K
N/AN/AN/A 
10.50M
25.2%72.6%N/A
1.72M
-51.7%-36.2%-20.9%
8.08M
-8.6%31.1%N/A
EHAB logo
Enhabit, Inc.
NYSE:EHAB
22.50M
-10.0%-9.4%N/A
21.12M
6.7%14.6%27.2%
4.45M
2.3%33.7%N/A
579.00K
-1.1%-1.6%2.5%
27.20M
-6.4%-6.1%N/A
SRDX logo
Surmodics, Inc.
NASDAQ:SRDX
8.69M
0.7%1.6%6.0%
CI

CeriBell, Inc. Fair Value Envelope

CBLL · NASDAQ

Our analysis suggests that CBLL has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $18.63, this represents a potential HIDDEN relative to our calculated worth for CeriBell, Inc..

Intrinsic Value
Current Price: $18.63